OBERWEIS ASSET MANAGEMENT INC/

Position in HALO — Halozyme Therapeutics, Inc.

CIK 937886 LISLE, IL

Position in HALO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$25,127,018

+$10,912,943 QoQ

Shares Held

321,030

+46.0% QoQ

Ownership

0.283%

of shares outstanding

% of Portfolio

0.52%

of 13F equity value

Holder Rank

#75

of 667 holders

Holding Since

Mar 2021

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

OBERWEIS ASSET MANAGEMENT INC/ holds $71,518,263 across 4 Biotechnology names. HALO ranks #2 (35.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARQT	Arcutis Biotherapeutics, Inc.	1,372,941	$35,998,513
2	HALO	Halozyme Therapeutics, Inc. This page	321,030	$25,127,018
3	CRMD	CorMedix Inc.	1,323,915	$10,392,732
4			293,670	$0

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$25,127,018	321,030	+46.0%	Shares	Sole	2026-08-14
2026-03-31	$14,214,075	219,930	+87.0%	Shares	Sole	2026-05-15
2025-12-31	$7,913,134	117,580	0.0%	Shares	Sole	2026-02-17
2025-09-30	$8,623,317	117,580	-35.5%	Shares	Sole	2025-11-17
2025-06-30	$9,478,044	182,200	+89.2%	Shares	Sole	2025-08-14
2023-12-31	$3,559,248	96,300	+90.7%	Shares	Sole	2024-02-14
2023-09-30	$1,929,100	50,500	-69.2%	Shares	Sole	2023-11-14
2023-03-31	$6,264,687	164,040	+14.4%	Shares	Sole	2023-05-15
2022-12-31	$8,158,891	143,390	+23.0%	Shares	Sole	2023-02-14
2022-09-30	$4,607,991	116,540	+13.1%	Shares	Sole	2022-11-14
2022-06-30	$4,534,200	103,050	-4.1%	Shares	Sole	2022-08-15
2022-03-31	$4,285,106	107,450	+1.7%	Shares	Sole	2022-05-16
2021-12-31	$4,248,186	105,650	+51.0%	Shares	Sole	2022-02-14
2021-09-30	$2,846,786	69,980	+1.1%	Shares	Sole	2021-11-15
2021-06-30	$3,142,372	69,200	+0.4%	Shares	Sole	2021-08-16
2021-03-31	$2,872,441	68,900	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.